“Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis” has been published in the journal Science Translational Medicine. This work was supported in part by JPND through the STRENGTH project, selected in the 2012 risk factors call.

April 7, 2017